We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BMEA market cap is 147.85M. The company's latest EPS is USD -3.2356 and P/E is -1.26.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -31.12M | -37.33M | -41.06M | -38.9M | -34.04M |
| Net Income | -28.43M | -34.88M | -39.06M | -37.28M | -32.79M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.2M | -5.33M | -41.67M | -83.63M | -126.14M |
| Net Income | -1.2M | -5.32M | -41.57M | -81.83M | -117.26M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 225.09M | 199.93M | 168.49M | 136.16M | 110.42M |
| Total Liabilities | 25.48M | 30.69M | 33.18M | 32.22M | 34.45M |
| Total Equity | 199.61M | 169.24M | 135.31M | 103.95M | 75.97M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 265k | 62.53M | 185.71M | 129.31M | 199.93M |
| Total Liabilities | 286k | 1.62M | 6.92M | 20.77M | 30.69M |
| Total Equity | -21k | 5.17M | 178.78M | 108.54M | 169.24M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -73.76M | -96.59M | -32.03M | -64.67M | -89.89M |
| Investing | -2.21M | -2.22M | -35k | -94k | -280k |
| Financing | 163.18M | 163.8M | 116k | 1.19M | 1.26M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.28M | -4.46M | -35.44M | -62.42M | -96.59M |
| Investing | N/A | -51k | -33.36M | 27.34M | -2.22M |
| Financing | 1.44M | 65.97M | 153.19M | 1.24M | 163.8M |
| Market Cap | 147.85M |
| Price to Earnings Ratio | -1.26 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.84 |
| Price to Book Ratio | 0.87 |
| Dividend Yield | - |
| Shares Outstanding | 36.24M |
| Average Volume (1 week) | 590.85k |
| Average Volume (1 Month) | 1.08M |
| 52 Week Change | -73.45% |
| 52 Week High | 20.21 |
| 52 Week Low | 3.65 |
| Spread (Intraday) | 0.43 (9.79%) |
| Company Name | Biomea Fusion Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.biomeafusion.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
